search
Back to results

Application of Carbon Nanoparticles in Laparoscopic Colorectal Surgery

Primary Purpose

Colorectal Tumor

Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Device: tumor localization
Sponsored by
Aiguo, Lu
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Colorectal Tumor

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

- Pathologically diagnosed as colorectal benign tumor or tumor with TNM staging I-III (including patients need further surgery after endoscopic treatment), Be able to tolerate laparoscopic radical resection With normal hepatic and renal function No history of abdominal surgery

Exclusion Criteria:

- Patients with distant metastasis, poor compliance, prior abdominal surgery Emergency case with obstruction or perforation Have received neoadjuvant chemotherapy or radiotherapy Patients diagnosed as familial adenomatous polyposis (FAP), Inflammatory bowel disease such as ulcerative colitis and Crohn's disease

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Active Comparator

    Active Comparator

    Experimental

    Arm Label

    Device:Titanium Clips

    Device:Intra-operative Endoscopy

    Device:Carbon Nanoparticles

    Arm Description

    Device: Tumor localization. Preoperative endoscopic localization with titanium clips

    Device: Tumor localization. During the laparoscopic surgery,tumor is localized using intra-operative endoscopy detection.

    Device: Tumor localization. During the laparoscopic surgery,tumor is localized using carbon nanoparticles.

    Outcomes

    Primary Outcome Measures

    Tumor localization time
    From abdominal exploration to tumor localization

    Secondary Outcome Measures

    survival data 1
    overall survival
    survival data 2
    disease free survival
    Post-operative complication rates
    According to the records in hospital
    Distal edge distance of specimen
    measured by two pathologists separately
    LN number dissected
    measured by two pathologists separately
    Length of stay
    According to the record in hospital
    Total operation time
    Measured according to operation record
    Blood loss
    Measured according to operation record

    Full Information

    First Posted
    November 5, 2017
    Last Updated
    November 18, 2017
    Sponsor
    Aiguo, Lu
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03350945
    Brief Title
    Application of Carbon Nanoparticles in Laparoscopic Colorectal Surgery
    Official Title
    Application of Carbon Nanoparticles in Laparoscopic Colorectal Surgery
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2017
    Overall Recruitment Status
    Unknown status
    Study Start Date
    December 1, 2017 (Anticipated)
    Primary Completion Date
    August 1, 2019 (Anticipated)
    Study Completion Date
    December 31, 2019 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor-Investigator
    Name of the Sponsor
    Aiguo, Lu

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The project aims to evaluate the safety, effectiveness, accuracy and economy efficiency of the application of carbon nanoparticles for tumor localization and lymph nodes mapping in the laparoscopic coloectal surgery.
    Detailed Description
    Colorectal cancer is among the most commonly diagnosed cancer in both men and women . Increasing studies have been focused on the causes and therapies of this disease in order to improve the prognosis. In recent decades, laparoscopy has been commonly used in both colorectal and gastric surgery due to the benefit of minimal invasive technology progression . Its comparable safety and effectiveness have been proved in many studies. The advantages of minimal invasive surgery such as faster recovery, less bleeding and less pain, have also been admitted by numerous surgeons . However, the accomplishment of operation procedures mainly depend on subjective experiences. Even skilled surgeons can be impeded in operation due to the deficiency of tactile sense . As a result, accurate intra-operative localization of tumor would be a tough task if it was invisible on the serosal surface or difficult to approach, such as small or flat neoplasms, tumor confined to the mucosa and submucosa and endoscopically resected polyps which required additional surgery . At present, three dominant methods can be available to locate tumor: preoperative endoscopic clip placement, intraoperative endoscopy and endoscopic tattooing. All of these methods have their advantages but also some unavoidable limitations, such as localization error and problems in the assessment of incision margin using preoperative clip placement, unsatisfactory operation exposure after intraoperative endoscopy, ink spillage or failure in finding lesions with dye endoscopic injection et al. Usually surgeons choose different methods according to the objective conditions such as the ability to perform endoscopy or the availability of suitable tattooing material. Apart from the precise localization of tumor, adequate lymph node dissection is another crucial point in colorectal operation. According to AJCC recommendation and NCCN guideline, the number of lymph nodes, which has been proved of prognostic and therapeutic importance, is clearly defined in colorectal cancer to make sure of the accurate pathological staging. Previous studies have found that the number of lymph nodes evaluated after surgical resection was positively associated with the survival of patients. Besides Total Mesorectal Excision (TME) and D3 lymph node clearance, which are standards in colorectal surgery over decades of research and accumulated data, the harvest of lymph nodes is still associated with pathological doctors' experience and pathological examination skills. However, population-based data suggest that lymph node evaluation is not adequate in the majority of patients . Some micro lymph nodes, especially with diameter less than 5 mm, are more easily missed in specimen process while rate of metastasis is comparably higher in these lymph nodes. As a result, clinicians are trying to find a lymph node tracer to help improve the amount of lymph node harvest as well as the rate of micro-metastasis in lymph node. Carbon nanoparticle has been used as a lymph node tracer for decades. As a lymphatic vessel specific dye material, there is no doubt in its effect on lymph node mapping. In recent years, surgeons have applied this tracer widely in breast and thyroid operations for sentinel lymph node mapping to determine dissection extent. The effectiveness and accuracy of this method has been verified in thyroid and breast surgery while there is rare study focused on its application in colorectal surgery. The application of tattooing material, such as methylene blue, India ink and nano-materials in tumor localization has also attracted attentions of clinicians. In our study, three groups based on different tumor localization means are compared on short-term benefits, cost-effectiveness and lymph node clearance in order to choose the best approach to locate tumor and validate lymph node staining effect of carbon nanoparticles.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Colorectal Tumor

    7. Study Design

    Primary Purpose
    Treatment
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderOutcomes Assessor
    Allocation
    Randomized
    Enrollment
    150 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Device:Titanium Clips
    Arm Type
    Active Comparator
    Arm Description
    Device: Tumor localization. Preoperative endoscopic localization with titanium clips
    Arm Title
    Device:Intra-operative Endoscopy
    Arm Type
    Active Comparator
    Arm Description
    Device: Tumor localization. During the laparoscopic surgery,tumor is localized using intra-operative endoscopy detection.
    Arm Title
    Device:Carbon Nanoparticles
    Arm Type
    Experimental
    Arm Description
    Device: Tumor localization. During the laparoscopic surgery,tumor is localized using carbon nanoparticles.
    Intervention Type
    Procedure
    Intervention Name(s)
    Device: tumor localization
    Intervention Description
    At present, three dominant methods can be available to locate tumor: preoperative endoscopic clip placement, intraoperative endoscopy and endoscopic tattooing
    Primary Outcome Measure Information:
    Title
    Tumor localization time
    Description
    From abdominal exploration to tumor localization
    Time Frame
    within 1 month
    Secondary Outcome Measure Information:
    Title
    survival data 1
    Description
    overall survival
    Time Frame
    within 5 year
    Title
    survival data 2
    Description
    disease free survival
    Time Frame
    within 5 year
    Title
    Post-operative complication rates
    Description
    According to the records in hospital
    Time Frame
    within 6 month
    Title
    Distal edge distance of specimen
    Description
    measured by two pathologists separately
    Time Frame
    within 2 weeks
    Title
    LN number dissected
    Description
    measured by two pathologists separately
    Time Frame
    within 2-3 weeks
    Title
    Length of stay
    Description
    According to the record in hospital
    Time Frame
    within a year
    Title
    Total operation time
    Description
    Measured according to operation record
    Time Frame
    within 1 week
    Title
    Blood loss
    Description
    Measured according to operation record
    Time Frame
    within 1 week

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: - Pathologically diagnosed as colorectal benign tumor or tumor with TNM staging I-III (including patients need further surgery after endoscopic treatment), Be able to tolerate laparoscopic radical resection With normal hepatic and renal function No history of abdominal surgery Exclusion Criteria: - Patients with distant metastasis, poor compliance, prior abdominal surgery Emergency case with obstruction or perforation Have received neoadjuvant chemotherapy or radiotherapy Patients diagnosed as familial adenomatous polyposis (FAP), Inflammatory bowel disease such as ulcerative colitis and Crohn's disease
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    di liu
    Phone
    +8615601725597
    Email
    lydia_liu1991@163.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Aiguo Lu
    Phone
    64370045
    Email
    lydia_liu1991@163.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Minhua Zheng
    Organizational Affiliation
    Ruijin Hospital
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Application of Carbon Nanoparticles in Laparoscopic Colorectal Surgery

    We'll reach out to this number within 24 hrs